MA
THRN

MYDA Advisors’s Thorne Healthtech, Inc. Common Stock THRN Stock Holding History

MYDA Advisors’s Portfolio THRN Stock Details THRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-133,144
Closed -$615K – 174
2023
Q1 		$615K Sell
133,144
-16,856
-11% -$74.2K 0.23% 67
2022
Q4 		$545K Buy
+150,000
New +$665K 0.34% 55
2022
Q3 		– Sell
-69,000
Closed -$334K – 224
2022
Q2 		$334K Sell
69,000
-56,000
-45% -$340K 0.09% 139
2022
Q1 		$795K Buy
125,000
+23,095
+23% +$124K 0.31% 96
2021
Q4 		$633K Sell
101,905
-25,095
-20% -$196K 0.17% 143
2021
Q3 		$1.1M Buy
+127,000
New +$1.04M 0.31% 85

Other funds holding THRN

EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MYDA Advisors's THRN Position: Q2 2023 in Review

MYDA Advisors sold out of Thorne Healthtech, Inc. Common Stock (THRN) in Q2 2023, closing a stake of 133,144 shares — an estimated $615K sold.

MYDA Advisors first reported a position in THRN in Q3 2021 and held it in 6 quarters. The position peaked at $1.1M in Q3 2021. 44 funds tracked by Wall St. Rank hold THRN as of Q2 2023.

  • MYDA Advisors reported no remaining Thorne Healthtech, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • MYDA Advisors sold 133,144 Thorne Healthtech, Inc. Common Stock shares in Q2 2023, an estimated $615K.
  • MYDA Advisors first reported a position in Thorne Healthtech, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
  • MYDA Advisors's Thorne Healthtech, Inc. Common Stock position peaked at $1.1M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Thorne Healthtech, Inc. Common Stock as of Q2 2023.

Based on MYDA Advisors's 13F filing for Q2 2023, filed 11 Aug 2023.